Assessment of Blood Flow in Hepatocellular Carcinoma: Correlations of Computed Tomography Perfusion Imaging and Circulating Angiogenic Factors

被引:16
作者
Chen, Ya-Wen [1 ,2 ]
Pan, Huay-Ben [3 ,4 ,5 ]
Tseng, Hui-Hwa [5 ,6 ]
Hung, Yu-Ting [3 ]
Huang, Jer-Shyung [3 ,5 ]
Chou, Chen-Pin [3 ,5 ,7 ]
机构
[1] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli 350, Taiwan
[2] China Med Univ, Grad Inst Basic Med Sci, Taichung 404, Taiwan
[3] Kaohsiung Vet Gen Hosp, Dept Radiol, Kaohsiung 813, Taiwan
[4] I Shou Univ, Dept Med Imaging & Radiol Sci, Kaohsiung 824, Taiwan
[5] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan
[6] Kaohsiung Vet Gen Hosp, Dept Pathol, Kaohsiung 813, Taiwan
[7] Fooyin Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung 807, Taiwan
关键词
hepatocellular carcinoma; blood flow; circulating angiogenic factors; CT perfusion; interleukin; 8; ENDOTHELIAL GROWTH-FACTOR; CIRRHOTIC LIVER-DISEASE; CONTRAST-ENHANCED MRI; TUMOR ANGIOGENESIS; TRANSARTERIAL CHEMOEMBOLIZATION; CT; INTERLEUKIN-8; CANCER; THALIDOMIDE; VASCULARITY;
D O I
10.3390/ijms140917536
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocellular carcinoma (HCC) is a highly vascular tumor through the process of angiogenesis. To evaluate more non-invasive techniques for assessment of blood flow (BF) in HCC, this study examined the relationships between BF of HCC measured by computer tomography (CT) perfusion imaging and four circulating angiogenic factors in HCC patients. Interleukin 6 (IL-6), interleukin 8 (IL-8), vascular endothelial growth factor (VEGF), and platelet derived growth factor (PDGF) in plasma were measured using Bio-Plex multiplex immunoassay in 21 HCC patients and eight healthy controls. Circulating IL-6, IL-8 and VEGF showed higher concentrations in HCC patients than in controls (p < 0.05), and predicted HCC occurrence better than chance (p < 0.01). Twenty-one patients with HCC received 21-phase liver imaging using a 64-slice CT. Total BF, arterial BF, portal BF, arterial fraction (arterial BF/total BF) of the HCC and surrounding liver parenchyma, and HCC-parenchyma ratio were measured using a dual-vessel model. After analyzing the correlations between BF in HCC and four circulating angiogenic factors, we found that the HCC-parenchyma ratio of arterial BF showed a significantly positive correlation with the level of circulating IL-8 (p < 0.05). This circulating biomarker, IL-8, provides a non-invasive tool for assessment of BF in HCC.
引用
收藏
页码:17536 / 17552
页数:17
相关论文
共 54 条
[1]   Arterial blood supply of hepatocellular carcinoma and histologic grading: Radiologic-pathologic correlation [J].
Asayama, Yoshiki ;
Yoshimitsu, Kengo ;
Nishihara, Yunosuke ;
Irie, Hiroyuki ;
Aishima, Shinichi ;
Taketomi, Akinobu ;
Honda, Hiroshi .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 190 (01) :W28-W34
[2]   Blood flow changes in hepatocellular carcinoma after the administration of thalidomide assessed by reperfusion kinetics during microbubble infusion -: Preliminary results [J].
Bertolotto, M ;
Pozzato, G ;
Crocè, LS ;
Nascimben, F ;
Gasparini, C ;
Cova, MA ;
Tribelli, C .
INVESTIGATIVE RADIOLOGY, 2006, 41 (01) :15-21
[3]   Biomarkers for monitoring antiangiogenic therapy [J].
Bhatt, Rupal S. ;
Seth, Pankaj ;
Sukhatme, Vikas P. .
CLINICAL CANCER RESEARCH, 2007, 13 (02) :777S-780S
[4]   Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[5]   Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma [J].
Chen, Guang ;
Ma, Da-Qing ;
He, Wen ;
Zhang, Bao-Feng ;
Zhao, Li-Qin .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (37) :5738-5743
[6]   Angiogenesis of renal cell carcinoma: perfusion CT findings [J].
Chen, Yan ;
Zhang, Jin ;
Dai, Jingrui ;
Feng, Xiaoli ;
Lu, Haizhen ;
Zhou, Chunwu .
ABDOMINAL IMAGING, 2010, 35 (05) :622-628
[7]   Tumor angiogenesis:: pathophysiology and implications for contrast-enhanced MRI and CT assessment [J].
Cuenod, CA ;
Fournier, L ;
Balvay, D ;
Guinebretière, JM .
ABDOMINAL IMAGING, 2006, 31 (02) :188-193
[8]   Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy [J].
Dvorak, HF .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (21) :4368-4380
[9]   Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to αvβ3 [J].
Ellegala, DB ;
Poi, HL ;
Carpenter, JE ;
Klibanov, AL ;
Kaul, S ;
Shaffrey, ME ;
Sklenar, J ;
Lindner, JR .
CIRCULATION, 2003, 108 (03) :336-341
[10]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182